Neuralink launched the first European clinical trial in the UK to test brain implants that let paralyzed patients control ...

Elon Musk's Neuralink is set to conduct a groundbreaking clinical study in Great Britain to test brain chips that allow patients with severe paralysis to control digital tools with their thoughts.

Neuralink is partnering with the University College London Hospitals trust and Newcastle Hospitals to conduct the study.

Elon Musk 's Neuralink is gearing up to conduct a clinical study in UK. The research will explore how its advanced brain chips can help patients with severe paralysis, control digital and physical ...

Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of ...

Neuralink, Elon Musk's brain implant company, is expanding its clinical trials to the UK after its US success. The trials aim ...

Targeted rewriting of the epigenome promises to overcome several challenges in direct gene editing in patient therapies.

A new study reveals that astrocyte-derived GABA, not neuronal activity, plays a central role in PTSD by impairing the brain’s ability to extinguish traumatic memories.

Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health ...

Losing teeth may no longer be a major concern. A drug that can regrow lost teeth is now preparing to enter human trials.

Centauri Therapeutics Limited ('Centauri'), an immunotherapy company with a unique and proprietary platform technology ...

The cowpea mosaic virus could provide an affordable and effective immunotherapy treatment if clinical trials are successful.